ArticleBritish journal of clinical pharmacology2018

Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.

Joop van Gerven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.